SXTC Stock Analysis: Buy, Sell, or Hold?
SXTC - China SXT Pharmaceuticals, Inc. Ordinary Shares
$2.46
0.07 (3.09%)
▲
5d:
+4.85%
30d:
+50.24%
90d:
+67.61%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Get Alerted When SXTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: SXTC is 12.5% above its trading range ($2.19). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: SXTC is 12.5% above its trading range ($2.19). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: SXTC is currently trading at $2.46, which is considered extended relative to its 30-day fair value range of $1.49 to $2.19.
Technical Outlook: Technically, SXTC is showing sideways momentum. The price is approaching resistance at $1.85. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: SXTC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SXTC is showing sideways momentum. The price is approaching resistance at $1.85. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: SXTC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.49 -
$2.19
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.1%
All Signals
- BEARISH: Price significantly overextended (+12.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+3.1%)
Trading Range Analysis
30-Day Trading Range
$1.49 -
$2.19
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.41
Resistance Level
$1.85
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Revenue Growth (YoY)
-24.5%
Earnings Growth (YoY)
42.6%
Share & Embed Analysis
Last updated: June 23, 2026 12:59 PM ET
Data refreshes hourly during market hours. Next update: 1:59 PM
Data refreshes hourly during market hours. Next update: 1:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SXTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 58 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 57 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 59 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 60 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 61 BUY |
